Second Covid-19 trial paused within 24 hours over safety concerns

Two late-stage Covid-19 medical trials have been paused in the space of 24 hours over potential safety concerns, the latest setbacks to scientists in the long fight against the pandemic. ​​​US pharmaceutical firm Eli Lilly on Tuesday suspended its Phase 3 trial of its lab-produced antibody treatment in hospitalized patients over an unspecified incident. Two late-stage Covid-19 medical trials have been paused in the space of 24 hours over potential safety concerns, the latest setbacks to scientists in the long fight against the pandemic. ​​​US pharmaceutical firm Eli Lilly on Tuesday suspended its Phase 3 trial of its lab-produced antibody treatment in hospitalized patients over an unspecified incident.

Leave a Reply

Your email address will not be published. Required fields are marked *